Patterns of CMV infection post renal transplant  by Sheldon, A. et al.
Abstracts / International Journal of Surgery 23 (2015) S15eS134S108Posters: Transplant Surgery0068: DEMOGRAPHIC FEATURES AND OUTCOME MEASURES FOR
UNDERWEIGHT RENAL TRANSPLANT RECIPIENTS: A SINGLE CENTRE
TEN-YEAR EXPERIENCE
S. Ebbs 1,*, J. Nath 2, B. Osman 2, M. Frank 1, A. Ready 2. 1University of
Birmingham, UK; 2University Hospital Birmingham NHS Foundation Trust,
UK
Aim: Obesity is increasing in the renal transplant population provoking
signiﬁcant clinical interest. However, outcomes for underweight
(BMI 18.5 kg/m2) patients have been poorly deﬁned. We present our ten-
year experience of underweight transplant recipients including functional
outcomes.
Methods: Consecutive adult patients undergoing renal transplantation
(January 2004-January 2014) at the Queen Elizabeth Hospital, Birmingham
were included and divided into two groups (BMI  18.5 and BMI> 18.5).
Demographic features and graft outcomes were obtained from a
contemporaneously maintained database.
Results: 33 of 1095 patients (3.01%) were underweight. These tended to be
female (60.6% vs 40.2% p< 0.001) and young (mean age 27.0 vs 46.7
p< 0.001). 1-year graft and patient survival values were similar for un-
derweight and non-underweight groups (90.9% vs 90.5% (p ¼ 0.005) and
97.0% vs 98.6% (p ¼ 0.460) respectively). Median creatinine at 12 months
was lower for the underweight group (107 mmol/L (88e135) vs 129 mmol/L
(105e162) p< 0.001).
Conclusion: Underweight renal transplant recipients are not representa-
tive of the overall transplant population and are more likely to be young
females. However such patients have excellent outcomes with comparable
graft and patient survival to non-underweight counterparts. Whilst ab-
solute creatinine values are lower in underweight patients, this may reﬂect
lower muscle mass and necessitates further study.
0088: NEW ONSET DIABETES AFTER TRANSPLANTATION: IS IT A BIG
DEAL? RISK FACTORS AND IMPACT AFTER KIDNEY
TRANSPLANTATION. A SINGLE CENTRE EXPERIENCE
J. Worsfold 1,*, L. Harris 1, E. Aboutaleb 2, E. Favi 2, R. Cacciola 2, C.
Puliatti 2, C. Sammartino 2, R. Sivaprakasam 2. 1Barts and the London
School of Medicine and Dentistry, UK; 2 The Royal London Hospital, UK
Aim: New Onset Diabetes after Transplantation (NODAT) can affect graft
and patient survival following renal transplantation. But there's a lack of
evidence in its effect on ethnic minority; in particular transplant patients
from Indian Sub-continent (ISC). We have reviewed our experience to
address this issue.
Methods: The data was collected from a prospectively collated database
from a single centre between 2007e2013. The data collected included
donor and recipient variables- age, sex, type of donor, ethnicity, BMI, co-
morbidities, cold ischemia time, graft and patient survival. A univariate
and multivariate analysis were performed using SPSS.
Results: A total of 639 patients were included in this population, 294
(46.1%) Caucasians and 345 (53.9 %) non-Caucasians with a mean age at
transplant of 45.6± 12.3. During a mean follow-up of 4.55 years, 62 (9.7%)
of the patients had NODAT, 16 (25.8%) were Caucasian and 43 (69.4%) were
non-Caucasian. The signiﬁcant risk factors are recipient age, from Indian
sub-continent, deceased donors and recipient body mass index and no
signiﬁcant difference was found in Co-variables.
Conclusion: Increased incidence of NODAT was found in the renal trans-
plant patients from ISC and despite published evidences; there is no sig-
niﬁcant effect on the graft and patient survival following transplantation.
0118: KNOWLEDGE AND OPINIONS HELD BY BRITISH AND CANADIAN
SIKHS REGARDING SOLID ORGAN AND STEM CELL TRANSPLANTATION
R.S. Andev*, M. Field. University of Birmingham, UK
Aim: British and Canadian Sikh membership to the stem cell and organ
donation registers are low. Previously, Sikhs were studied collectively withthe other heterogeneous South Asian communities, creating unfocussed
results. Recent British stem cell campaigns have spurred a 1,200% increase
of South Asians on the register possibly due to targeted campaigns.
Methods: Our online questionnaire assessed stem cell and organ donation
knowledge and belief among Sikhs.
Results: Organ donation registry is similar for British (35.5%, n ¼ 43) and
Canadian Sikhs (36.0%, n ¼ 40). However, British Sikhs are more likely to
be stem cell donor registrants (28.1%, n ¼ 34) compared to Canadians
(13.5%, n ¼ 15). The main reason British Sikhs joined the stem cell register
was due to a targeted campaign (45%, n ¼ 54). Knowledge on stem cell
donation is poor compared to organ donation (p< 0.01). The main reason
for lack of registration to either the stem cell or organ donation register is
having ‘never considered’ joining, at 69% (n ¼ 161) and 52% (n ¼ 121)
respectively.
Conclusion: There are increased numbers of British Sikhs on the stem cell
register but they appear to know less. Targeted campaigns could increase
membership, but this needs to be balanced with a good knowledge base
for registry.
0172: PATTERNS OF CMV INFECTION POST RENAL TRANSPLANT
A. Sheldon*, P. Thomson, M. Clancy. University of Glasgow, UK
Aim: CMV infection post renal transplant is most common in seroneg-
ative recipients of seropositive donors (Donor+/Recipient-) leading to
widespread use of antiviral prophylaxis. Non-prohylaxed, combinations
manifest a lower incidence. We evaluate incidence and timing of
CMV viraemia and disease in all donor/recipient serological
combinations.
Methods: This study included consecutive renal transplant patients 1/7/
10-30/6/13 with a minimum of 1 year follow-up. Demographic data,
donor/recipient pre-transplant CMV status, and post-transplant
CMV PCR were extracted from a prospectively compiled, electronic
patient record. Time to CMV DNA PCR positivity was calculated in all
groups.
Results: Pre-transplant CMV status was established for 294/335(87.7%)
transplantations. 23.5%(69/294) were in the prophylaxis group (D+/R).
43.5%(30/69) of the prophylaxis group encountered CMV viraemia post-
transplant [27.5%(19/69)symptomatic] versus 8.9%(20/225) in the non-
prophylaxis group [1.8% (4/225)symptomatic]. Peak incidence of CMV
viraemia was at 90-days in the non-prophylaxis group compared to 270
days post-transplant in the prophylaxis group.
Conclusion: CMV viraemia occurs in the high risk group despite prophy-
laxis but mostly later than 6 months post transplant. Clinicians should
maintain a high level of clinical suspicion for CMV infection in non-pro-
phylaxed patients early post-transplant. In prophylaxed patients, infection
is more likely 6e18 months post-transplant.
0390: DEALING WITH THE DEFICIT: SEROPOSITIVE-TO-SEROPOSITIVE
ORGAN TRANSPLANTATION IN PATIENTS WITH HIV
M.J. Hussain*. Central Manchester University Hospital Foundation Trust, UK
Aim: In the HAART-age, survival has improved amongst patients with HIV.
A new ageing population has emerged with chronic conditions, necessi-
tating the need for organ transplantation. Organ transplantation in sero-
positive recipients has shown comparable patient and graft survival
compared to seronegative recipients. But the donor pool is limited.
Methods: Multiple databases were systematically searched (inception to
October 2014) using keywords: HIV-positive, Recipient, Donor, Trans-
plantation, Kidney, Pancreas.
Results: Limited data exists evaluating the viability and prospect of sero-
positive-seropositive organ transplantation. To date 14 seropositive-sero-
positive renal transplants, using anti-thymocyte globulin induction
therapy have been reported with good graft function and dialysis-free at
12 months. Over 60% of seropositive individuals are agreeable to organ
donation, with 55% open to receiving seropositive organs. Concerns of
infection, quality of organ and conﬁdentiality were barriers to seroposi-
tive-seropositive organ transplantation. Uncertainty and stigma still exists
around performing transplants in seropositive recipients among trans-
plant practitioners.
